Abstract: A process for obtaining a product of high iron content and high physical and metallurgical performance for use in reduction furnaces (blast furnaces, and direct reduction) and melting furnaces (smelters, melters, and electric furnaces), aiming at the sustainable production of iron and steel. The process includes mixing iron ore fines with biomass, binders, nanomaterials, additives, and catalysts, and performing subsequent steps of comminution, agglomeration, heat treatment, solid-solid separation, and coating.

Abstract: Disclosed herein are methods and systems for identifying one or more potential biomarkers for a clinical outcome related to administration of an agent. The method includes processing molecular profile data for a plurality of subjects where the molecular profile data includes data obtained before, during and/or after administration of an agent to the plurality of subjects. The method also includes processing clinical records data for the subjects, where the clinical records data includes clinical outcome data, integrating the processed molecular profile data and the processed clinical records data for the subjects and storing in a database as merged data, selecting two or more subsets of the merged data using one or more criteria based on the clinical records data to generate two or more selected data sets, and analyzing one or more of the selected data sets to identify one or more potential biomarkers for a clinical outcome related to administration of the agent.

Abstract: The present invention relates to a device for heating materials using microwaves, particularly applicable to the heating of ore products, which makes it possible to eliminate the use of fossil fuels (for example natural gas, coal, fuel oil, etc.) for generating heat for heating this type of material, rendering viable the use of microwaves for heating materials through a more efficient dispersion of the electromagnetic waves thereof. The present invention also relates to systems that make use of the heating device as set out above, and a method for heating using microwaves.

Abstract: Methods for diagnosing the presence of prostate cancer in a subject are provided, such methods including the detection of levels of a variety of biomarkers diagnostic of prostate cancer. The invention also provides methods of treating prostate cancer by administering a biomarker or an agent that modulates a biomarker of prostate cancer. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.

Abstract: Methods for diagnosing the presence of prostate cancer in a subject are provided, such methods including the detection of levels of a variety of biomarkers diagnostic of prostate cancer. The invention also provides methods of treating prostate cancer by administering a biomarker or an agent that modulates a biomarker of prostate cancer. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.

Abstract: Methods for diagnosing the presence of BCR in prostate cancer in a subject are provided, such methods including the detection of levels of a variety of biomarkers diagnostic of BCR. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.

Abstract: Disclosed herein are methods and systems for identifying one or more potential biomarkers for a clinical outcome related to administration of an agent. The method includes processing molecular profile data for a plurality of subjects where the molecular profile data includes data obtained before, during and/or after administration of an agent to the plurality of subjects. The method also includes processing clinical records data for the subjects, where the clinical records data includes clinical outcome data, integrating the processed molecular profile data and the processed clinical records data for the subjects and storing in a database as merged data, selecting two or more subsets of the merged data using one or more criteria based on the clinical records data to generate two or more selected data sets, and analyzing one or more of the selected data sets to identify one or more potential biomarkers for a clinical outcome related to administration of the agent.

Abstract: Ultra-light oil texture cosmetic compositions suitable for being applied on the facial skin are provided. The compositions are used in the treatment and prevention of cutaneous stress and signs of extrinsic aging, particularly caused by external pollution aggressors.

Abstract: Methods for diagnosing the presence of prostate cancer in a subject are provided, such methods including the detection of levels of a variety of biomarkers diagnostic of prostate cancer. The invention also provides methods of treating prostate cancer by administering a biomarker or an agent that modulates a biomarker of prostate cancer. Compositions in the form of kits and panels of reagents for detecting the biomarkers of the invention are also provided.

Abstract: The present invention provides cosmetic compositions useful in protection to moisture and in resistance to sweat, comprising a synergistic combination of sweat adsorbent and absorbent particles.